Wednesday, September 5, 2007

Panel: HIV drug merits quick approval (AP)



AP - An experimental HIV drug from Merck & Co. Inc. should be quickly approved for use by patients running out of treatment options, federal advisers recommended Wednesday.

Source: http://rss.news.yahoo.com

No comments: